Identification of HER2 amplification by NGS in HER2-positive breast carcinomas with negative HER2 IHC results is important to reveal those cases that are hidden by our current HER2 test strategy with IHC first (for all cases) and FISH reflex (only for cases with IHC score of 2 +). Here, ERBB2 is linked to breast carcinoma.